Mark Mallon Neogenomics Inc (NEO) insider trading activity

NEO Quotes by TradingView

Mark Mallon is Chief Executive Officer of NEOGENOMICS INC. Currently has a direct ownership of 368,051 shares of NEO, which is worth approximately $5.05 Million. The most recent transaction as insider was on Mar 01, 2022, when has been sold 142,457 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 368K
0% 3M change
0% 12M change
Total Value Held $5.05 Million

Mark Mallon Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 01 2022
BUY
Grant, award, or other acquisition
-
142,457 Added 27.9%
368,051 Common Stock
Dec 30 2021
BUY
Grant, award, or other acquisition
-
152,858 Added 40.39%
225,594 Common Stock
Dec 06 2021
BUY
Open market or private purchase
$520,710 $30.63 p/Share
17,000 Added 18.94%
72,736 Common Stock
Apr 19 2021
BUY
Grant, award, or other acquisition
-
55,736 Added 50.0%
55,736 Common Stock

Also insider at

IRWD
IRONWOOD PHARMACEUTICALS INC Healthcare
Chief Executive Officer
MM

Mark Mallon

Chief Executive Officer
Boston, MA

Track Institutional and Insider Activities on NEO

Follow NEOGENOMICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NEO shares.

Notify only if

Insider Trading

Get notified when an Neogenomics Inc insider buys or sells NEO shares.

Notify only if

News

Receive news related to NEOGENOMICS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NEO